Busby JE - Search Results

1

Targeting platelet-derived growth factor receptor on endothelial cells of multidrug-resistant prostate cancer.

Kim SJ, Uehara H, Yazici S, Busby JE, Nakamura T, He J, Maya M, Logothetis C, Mathew P, Wang X, Do KA, Fan D, Fidler IJ. Kim SJ, et al. Among authors: busby je. J Natl Cancer Inst. 2006 Jun 7;98(11):783-93. doi: 10.1093/jnci/djj211. J Natl Cancer Inst. 2006. PMID: 16757703

2

Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice.

Yazici S, Kim SJ, Busby JE, He J, Thaker P, Yokoi K, Fan D, Fidler IJ. Yazici S, et al. Among authors: busby je. Prostate. 2005 Nov 1;65(3):203-15. doi: 10.1002/pros.20283. Prostate. 2005. PMID: 15948138

3

Therapy of multidrug resistant human prostate tumors in the prostate of nude mice by simultaneous targeting of the epidermal growth factor receptor and vascular endothelial growth factor receptor on tumor-associated endothelial cells.

Busby JE, Kim SJ, Yazici S, Nakamura T, Kim JS, He J, Maya M, Wang X, Do KA, Fan D, Fidler IJ. Busby JE, et al. Prostate. 2006 Dec 1;66(16):1788-98. doi: 10.1002/pros.20519. Prostate. 2006. PMID: 17013882

4

Treatment outcomes of small cell carcinoma of the prostate: a single-center study.

Spiess PE, Pettaway CA, Vakar-Lopez F, Kassouf W, Wang X, Busby JE, Do KA, Davuluri R, Tannir NM. Spiess PE, et al. Among authors: busby je. Cancer. 2007 Oct 15;110(8):1729-37. doi: 10.1002/cncr.22971. Cancer. 2007. PMID: 17786954 Free article. Clinical Trial.

5

What's new in the management of penile cancer?

Busby JE, Pettaway CA. Busby JE, et al. Curr Opin Urol. 2005 Sep;15(5):350-7. doi: 10.1097/01.mou.0000171521.86380.c9. Curr Opin Urol. 2005. PMID: 16093861 Review.

6

Chemoprevention for bladder cancer.

Busby JE, Kamat AM. Busby JE, et al. J Urol. 2006 Nov;176(5):1914-20. doi: 10.1016/j.juro.2006.07.004. J Urol. 2006. PMID: 17070211 Review.

7

Surgically managed lymph node-positive prostate cancer: does delaying hormonal therapy worsen the outcome?

Spiess PE, Lee AK, Busby JE, Jordan JJ, Hernandez M, Burt K, Troncoso P, Merriman KW, Pisters LL. Spiess PE, et al. Among authors: busby je. BJU Int. 2007 Feb;99(2):321-5. doi: 10.1111/j.1464-410X.2006.06648.x. Epub 2006 Nov 28. BJU Int. 2007. PMID: 17155975

8

Can digital rectal examination or transrectal ultrasonography biopsy findings predict the side of nodal metastasis in prostate cancer?

Spiess PE, Busby JE, Jordan JJ, Steinberg JR, Bassett RL, Davuluri R, Burt K, Troncoso P, Lee AK, Taylor SH, Pisters LL. Spiess PE, et al. Among authors: busby je. Urol Oncol. 2008 Jan-Feb;26(1):25-30. doi: 10.1016/j.urolonc.2006.12.019. Epub 2007 Oct 18. Urol Oncol. 2008. PMID: 18190826

9

Association between lymph node density and disease specific survival in patients with penile cancer.

Svatek RS, Munsell M, Kincaid JM, Hegarty P, Slaton JW, Busby JE, Gaston KE, Spiess PE, Pagliaro LC, Tamboli P, Pettaway CA. Svatek RS, et al. Among authors: busby je. J Urol. 2009 Dec;182(6):2721-7. doi: 10.1016/j.juro.2009.08.029. Epub 2009 Oct 17. J Urol. 2009. PMID: 19837433

10

Angiogenesis is not mediated by prostate cancer neuropeptides.

Busby JE, Shih SJ, Yang JC, Kung HJ, Evans CP. Busby JE, et al. Angiogenesis. 2003;6(4):289-93. doi: 10.1023/B:AGEN.0000029409.94626.64. Angiogenesis. 2003. PMID: 15166497

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters